Lillian Jean Gehue1, Elizabeth Scott2, Daniel Francis Hermens3, Jan Scott4, Ian Hickie5. 1. Clinical Research Unit, Brain and Mind Research Institute, The University of Sydney, Sydney, NSW, Australia. gehue@icloud.com. 2. Clinical Research Unit, Brain and Mind Research Institute, The University of Sydney, Sydney, NSW, Australia. escott@sydney.edu.au. 3. Clinical Research Unit, Brain and Mind Research Institute, The University of Sydney, Sydney, NSW, Australia. dhermens@sydney.edu.au. 4. Academic Psychiatry, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. jan.scott@newcastle.ac.uk. 5. Clinical Research Unit, Brain and Mind Research Institute, The University of Sydney, Sydney, NSW, Australia. Ian.hickie@sydney.edu.au.
Abstract
BACKGROUND: It is increasingly acknowledged that clinical interventions for young persons with mental disorders need to optimize social, vocational and physical functioning, and take into account developmental needs, rather than focusing only on the traditional target of psychiatric symptom change. However, few interventions for youth presenting to mental health services offer a coherent rationale for multi-faceted approaches that efficiently address all these targets. This trial uses two facilitated group therapy modules (social and physical activity) as a vehicle for promoting clinical, cognitive, social and vocational change. The modules are an adjunct to usual treatments offered to youth attending mental health services in Sydney, Australia. METHODS/ DESIGN: The design is a 2-arm, parallel group cross-over, randomized clinical trial (RCT) that examines the efficacy of this adjunctive youth early intervention program (called "YES") for improving social, vocational, mental and physical health functioning in a trans-diagnostic sample of 120 young persons aged 14-25 years who are currently receiving a range of "usual treatments" for clinically diagnosed anxiety, affective and/or psychotic disorders. Individuals who provide written informed consent are offered 2 group therapy modules (each comprising 4 hours per week for 8 weeks) with a 3-week "pause" between modules. Randomization determines whether individuals commence with module A or module B. The sample will be assessed pre-randomization, and at week 1 and week 8 (after completion of the first module), and at week 11 (commencement of second module) and week 19 (completion of second module). Final follow-up is 1-year post trial entry. DISCUSSION: If the findings of this exploratory trial demonstrate benefits in the target domains, then it will be important to extend the research by undertaking: (a) a comparison of the YES program to a control intervention in a randomized controlled trial, (b) an explanatory study of putative mediators of change, and (c) a multi-center trial with a number of trained therapists offering the group modules combined with a longer follow-up period. TRIAL REGISTRATION: Australian New Zealand Controlled Trial Registration: ACTRN1262400175673 , Date: 16 July 2015.
RCT Entities:
BACKGROUND: It is increasingly acknowledged that clinical interventions for young persons with mental disorders need to optimize social, vocational and physical functioning, and take into account developmental needs, rather than focusing only on the traditional target of psychiatric symptom change. However, few interventions for youth presenting to mental health services offer a coherent rationale for multi-faceted approaches that efficiently address all these targets. This trial uses two facilitated group therapy modules (social and physical activity) as a vehicle for promoting clinical, cognitive, social and vocational change. The modules are an adjunct to usual treatments offered to youth attending mental health services in Sydney, Australia. METHODS/ DESIGN: The design is a 2-arm, parallel group cross-over, randomized clinical trial (RCT) that examines the efficacy of this adjunctive youth early intervention program (called "YES") for improving social, vocational, mental and physical health functioning in a trans-diagnostic sample of 120 young persons aged 14-25 years who are currently receiving a range of "usual treatments" for clinically diagnosed anxiety, affective and/or psychotic disorders. Individuals who provide written informed consent are offered 2 group therapy modules (each comprising 4 hours per week for 8 weeks) with a 3-week "pause" between modules. Randomization determines whether individuals commence with module A or module B. The sample will be assessed pre-randomization, and at week 1 and week 8 (after completion of the first module), and at week 11 (commencement of second module) and week 19 (completion of second module). Final follow-up is 1-year post trial entry. DISCUSSION: If the findings of this exploratory trial demonstrate benefits in the target domains, then it will be important to extend the research by undertaking: (a) a comparison of the YES program to a control intervention in a randomized controlled trial, (b) an explanatory study of putative mediators of change, and (c) a multi-center trial with a number of trained therapists offering the group modules combined with a longer follow-up period. TRIAL REGISTRATION: Australian New Zealand Controlled Trial Registration: ACTRN1262400175673 , Date: 16 July 2015.
Authors: Ronald C Kessler; Peggy R Barker; Lisa J Colpe; Joan F Epstein; Joseph C Gfroerer; Eva Hiripi; Mary J Howes; Sharon-Lise T Normand; Ronald W Manderscheid; Ellen E Walters; Alan M Zaslavsky Journal: Arch Gen Psychiatry Date: 2003-02
Authors: Ronald C Kessler; G Paul Amminger; Sergio Aguilar-Gaxiola; Jordi Alonso; Sing Lee; T Bedirhan Ustün Journal: Curr Opin Psychiatry Date: 2007-07 Impact factor: 4.741
Authors: Anabel Martínez-Arán; Carla Torrent; Brisa Solé; C Mar Bonnín; Adriane R Rosa; José Sánchez-Moreno; Eduard Vieta Journal: Clin Pract Epidemiol Ment Health Date: 2011-06-06
Authors: Elizabeth M Scott; Daniel F Hermens; Django White; Sharon L Naismith; Jeanne GeHue; Bradley G Whitwell; Nick Glozier; Ian B Hickie Journal: BMJ Open Date: 2015-03-27 Impact factor: 2.692
Authors: Daniel F Hermens; Elizabeth M Scott; Django White; Marta Lynch; Jim Lagopoulos; Bradley G Whitwell; Sharon L Naismith; Ian B Hickie Journal: BMJ Open Date: 2013-02-04 Impact factor: 2.692